Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychiatric drugs
CRO
Headlands acquires Pharmasite to expand mental health trials
Headlands Research has acquired Pharmasite Research, a clinical trial site outside Baltimore that runs trials on psychiatric and CNS conditions.
Helen Floersh
Feb 29, 2024 4:20pm
Alto Neuroscience preps IPO to push CNS therapies through clinic
Jan 16, 2024 6:51am
Oryzon med fails to improve borderline personality disorder
Jan 7, 2024 4:17pm
AbbVie pads neuroscience portfolio with $8.7B Cerevel deal
Dec 6, 2023 5:19pm
Alto's 2nd precision psychiatry med improves depression symptoms
Dec 4, 2023 5:00pm
Karuna's journey from 'serendipitous clinical finding' to FDA
Oct 4, 2023 6:00am